STAGE III RECTAL CANCER AJCC V7
Clinical trials for STAGE III RECTAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat colorectal cancer: targeted drug combo tested
Disease control CompletedThis study tested two different drug combinations in 240 people with advanced colorectal cancer that has a specific genetic change called HER2 amplification. One group received a combination of two targeted antibodies (trastuzumab and pertuzumab), while the other received a stand…
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
New combo therapy shows promise in shrinking rectal tumors
Disease control CompletedThis study tested whether adding either veliparib or pembrolizumab to standard chemotherapy and radiation could better shrink tumors in people with locally advanced rectal cancer. 363 participants received one of the drug combinations before surgery. The goal was to see if these …
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:46 UTC